Medis Celebrates 35th Anniversary
18 Nov 2024 //
GLOBENEWSWIRE
Medis has appointed a new CEO
01 Aug 2023 //
PR NEWSWIRE
World Orphan Drug Alliance – partnering with Decisive Consulting to broaden
14 Nov 2022 //
PRNEWSWIRE
WODA combining forces to reach patients with rare diseases across globe
13 May 2022 //
BIOSPECTRUMASIA
Medis to commercialise Lupin’s orphan drug NaMuscla to treat myotonia in adults
10 Feb 2022 //
PHARMABIZ
Bial and Medis to enter partnership on CNS treatments
20 Jul 2021 //
PHARMAFILE
Alimera Sciences & Medis Pharmaceutical sign agreement to Commercialize Iluvien
15 Sep 2020 //
BIOSPACE